Funding will enable lead candidates CTX114 and CTX203 for AMD to enter clinical trials in the next year JERSEY CITY, N.J.--(BUSINESS WIRE)--Character Biosciences, a precision medicine company ...

Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, neuroendocrine, and neuropsychiatric disorders in the United States and internationally. The company ...

We're fourth in the UK in terms of the quality of our research (REF 2021). In the REF 2021, 98 per cent of research and impact from the School of Biosciences has been classed as world-leading or ...

After hours: March 26 at 7:51:40 PM EDT Loading Chart for HBIO ...

After hours: March 24 at 4:11:32 PM EDT Loading Chart for DARE ...

Impact and progress Frontiers' impact All annual reports Annual report 2024 ...